Life Sciences Notes | Herbert Smith Freehills Kramer | Global law firm

All blog posts

Search all blogs

Total 43 results for

Clear all filters

EU

The EU Commission's new draft merger guidelines - key takeaways for pharma companies

Venture investment in life sciences – Activity update & outlook (US & Europe)

EU Regulatory Reform for Medicinal Products: Bolar exemption

EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency

EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities

Recent additions to Life Sciences Notes

Overview of EU regulatory and competition law in the Pharma sector

HSF publishes Practical Law practice note on the Unitary Patent

HSF Patent team named best in Europe by Managing IP

Recent additions to Life Sciences Notes

Five Years of Activity in a Priority Sector: The European Commission's Report on Competition Enforcement in the Pharmaceutical Sector (2018-2022)

With the Headquarters Agreement for the Milan seat concluded, we look at the role of the UPC central division

Showing 12 out of 43 results

View more

Key contacts

Laura Orlando

Managing Partner, Milan Office, Milan

Alan Montgomery

Partner, Head of Pharmaceuticals Sector, Chair of India Group, London

Chris Parker KC

Partner, Head of Pharmaceuticals Sector, London